Analysts See Upside Potential for Key ETFs and Holdings

Analysts predict significant upside for the John Hancock Multifactor Mid Cap ETF (JHMM) and its underlying holdings. Investors should consider this bullish outlook for Amdocs (DOX), SPS Commerce (SPSC), and Charles River Laboratories (CRL).

Date: 06-01-2025

AI Rating: 7

Analyst Target Prices and Upside Potential
According to the report, the John Hancock Multifactor Mid Cap ETF (JHMM) has an implied analyst target price of $69.35, while its recent trading price is at $60.32, indicating a potential upside of 14.97%. The individual performance of JHMM's underlying holdings also reflects notable upside potential. Amdocs Ltd. (DOX) is trading at $84.17, with an average analyst target price of $100.86, suggesting an attractive upside of 19.83%. Similarly, SPS Commerce, Inc. (SPSC) and Charles River Laboratories, Inc. (CRL) have potential upsides of 19.72% and 15.03% from their respective recent trading prices of $186.85 and $185.80 compared to their average analyst target prices of $223.70 and $213.73, respectively.

This forecast can influence stock prices positively as it indicates analyst confidence in these companies' future performance. If investor sentiment aligns with these targets, buying interest could drive up the share prices of JHMM, DOX, SPSC, and CRL.
Investor Research Considerations
However, the report raises the question of whether analysts are overly optimistic or justified in these targets. It's vital for investors to conduct further research to assess whether recent company and industry developments support these forecasts. If there are substantial discrepancies between actual performance and analyst expectations, there could be price corrections or downgrades in target prices ahead.

Stocks: JHMM DOX SPSC CRL